Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Skin irritation testing is a fundamental toxicological endpoint required for the hazard characterization and regulatory registration of new chemical substances under frameworks such as REACH, China MEE Order No. 12, and the UN GHS classification system. This article provides a technical overview of accepted in vitro and in vivo test methods, applicable OECD and ISO standards, sample requirements, and typical applications across industrial, agrochemical, and consumer product sectors. Understanding the integrated testing strategy for skin corrosion and irritation helps manufacturers streamline compliance while minimizing animal use.

Technical Overview

Skin irritation testing for new chemical substances evaluates the potential of a chemical to cause reversible damage to the skin following single or short-term topical exposure. The endpoint is distinguished from skin corrosion, which refers to the production of irreversible tissue damage manifest as visible necrosis of the epidermis and dermis. Regulatory authorities worldwide, including those administering the EU REACH Regulation, the United States TSCA, and China's Measures for Environmental Management Registration of New Chemical Substances, require dermal irritation and corrosion data as part of the standard information package for new chemical registration.

Modern hazard assessment follows a tiered, integrated strategy consistent with the OECD Integrated Approach to Testing and Assessment (IATA). The evaluation typically begins with an assessment of existing data and physicochemical properties, followed by validated in vitro methods using reconstructed human epidermis (RhE) models, with in vivo rabbit testing reserved only for situations where alternative methods cannot deliver a conclusive classification. This approach aligns with international animal welfare principles and the 3R concept of replacement, reduction, and refinement.

Test outcomes feed directly into Globally Harmonized System (GHS) classification, resulting in hazard categories such as Skin Corrosive Category 1 (subdivided into 1A, 1B, and 1C) and Skin Irritant Category 2, which in turn determine labeling, packaging, safety data sheet content, and occupational handling controls.

Testing Samples

Pure New Chemical Substances

Registered intermediates, monomers, and specialty chemicals submitted for new chemical notification require skin irritation assessment as a base-set toxicological endpoint. Solid, liquid, and viscous substances are all acceptable, with sample preparation adjusted according to physical state.

Multi-Component Constituents and Mixtures

Reaction masses, unknown or variable composition complex substances (UVCBs), and formulated products may be tested directly or evaluated through mixture rules and additivity calculations based on component data when appropriate.

Agrochemical and Biocidal Active Ingredients

Pesticide and biocide actives typically require a complete dermal toxicity profile, including irritation and corrosion endpoints, to support product authorization and label statements.

Cosmetic and Consumer Product Ingredients

Although finished cosmetics in many jurisdictions prohibit animal testing, new chemical ingredients intended for downstream consumer applications rely heavily on in vitro RhE methods for hazard identification and risk assessment support.

Industrial Surface-Treatment and Processing Chemicals

Acids, alkalis, surfactants, solvents, and metal-working fluids used in manufacturing environments require irritation data to establish worker protection measures and emergency response protocols.

Testing Items

  • In vitro skin corrosion testing using reconstructed human epidermis models
  • In vitro skin corrosion testing using the transcutaneous electrical resistance (TER) method
  • In vitro membrane barrier test for skin corrosion screening
  • In vitro skin irritation testing using RhE tissue models
  • In vivo acute dermal irritation and corrosion testing (conditional, when alternatives are inconclusive)
  • Physicochemical screening for corrosive potential, including extreme pH and acid or alkali reserve
  • In silico and read-across assessment using QSAR models and structurally analogous chemicals
  • Phototoxicity and photo-irritation screening for UV-absorbing substances, where applicable

Testing Methods

In Vitro Reconstructed Human Epidermis Test Method (OECD TG 431 / TG 439)

The RhE test uses three-dimensional human skin models comprising non-transformed human-derived epidermal keratinocytes cultured to form a multilayered, differentiated epidermis. The test chemical is applied topically to the tissue surface for a defined exposure period, after which cytotoxicity is quantified using the MTT viability assay. OECD TG 431 addresses corrosion, where reduced viability after short exposure durations distinguishes corrosive from non-corrosive materials and supports subcategorization. OECD TG 439 addresses irritation, typically using a 42 percent viability threshold relative to negative controls to identify chemicals requiring classification as skin irritants.

Transcutaneous Electrical Resistance Test (OECD TG 430)

The TER method detects skin corrosion by measuring the loss of normal stratum corneum integrity and barrier function following chemical exposure. Corrosive chemicals destroy the skin barrier, producing a measurable and abrupt drop in electrical resistance across excited rat epidermal membranes. The method is accepted for identifying corrosive substances but does not distinguish among GHS subcategories or identify skin irritants.

Membrane Barrier Test Method (OECD TG 435)

This method evaluates corrosion by monitoring chemical penetration through an artificial macromolecular bio-barrier designed to mimic the stratum corneum. Detection of a color indicator or the erosion of the barrier itself signals corrosive potential, making the method particularly suited to screening large numbers of industrial chemicals.

In Vivo Acute Dermal Irritation and Corrosion Test (OECD TG 404 / GB/T 21604)

The traditional in vivo method involves a single dermal application of the test substance to the clipped skin of a rabbit, followed by scoring of erythema and eschar formation as well as edema at defined time intervals using the Draize grading system. A sequential testing strategy is mandatory: strong acids or bases, or chemicals demonstrated corrosive in vitro, must not proceed to animal testing. OECD TG 404 and the corresponding Chinese national standard GB/T 21604 specify humane endpoints, exposure durations, and observation periods that guide classification decisions.

Chinese National Standards and Supplementary Procedures

For domestic notification in China, GB/T 21604 covers the acute dermal irritation and corrosion procedure, while GB/T 27828 specifies the in vitro skin irritation test using RhE models, harmonized with the corresponding OECD guidelines. ISO 10993-10 provides irritation and sensitization test protocols for chemicals and materials intended for medical device applications, expanding the applicable scope of irritation testing beyond pure industrial chemicals.

Weight-of-Evidence and Integrated Approaches

Before any laboratory work, existing human and animal data, structural alerts, extreme pH values, and validated QSAR predictions are assembled into a weight-of-evidence assessment. This integrated approach, endorsed by ECHA guidance and OECD IATA documents, frequently resolves the classification question without additional testing or reduces the number of animals required when in vivo confirmation becomes necessary.

Applications

  • New chemical substance registration and notification under China MEE Order No. 12 for both routine and simplified registration tracks
  • REACH registration dossiers in the EU, where dermal irritation and corrosion data are standard Annex VII requirements
  • Pre-Manufacture Notifications (PMN) and TSCA submissions in the United States
  • GHS hazard classification and labeling for transport, workplace, and consumer contexts
  • Preparation of Section 11 toxicological information in safety data sheets
  • Occupational exposure control, personal protective equipment selection, and first-aid guidance
  • Downstream formulation development and substitution studies for safer chemical design
  • Support for chemical safety assessment reports submitted to regulatory authorities

FAQ

Is animal testing still required for skin irritation assessment of new chemicals?

In most regulatory frameworks, in vivo rabbit testing is now a last resort. Validated in vitro methods under OECD TG 431, TG 435, TG 430, and TG 439 are accepted as standalone approaches for corrosion and for positive irritation findings. In vivo testing is generally triggered only when in vitro results are negative but structural or physicochemical concerns remain, and it must follow the sequential, humane strategy defined in OECD TG 404.

What is the difference between skin irritation and skin corrosion?

Skin irritation refers to the production of reversible damage to the skin following exposure, observable as erythema and edema that heal within a defined observation period. Skin corrosion involves irreversible tissue damage, visible necrosis through the epidermis and into the dermis, and ulcers or scarring. Corrosive substances are classified under GHS Category 1 with subcategories 1A, 1B, and 1C based on the time required for the effect to appear.

How much sample is needed for a standard in vitro irritation test?

For liquids, a standardized application volume of approximately 50 microliters per tissue is required across replicate tissues and exposure conditions, so a practical submission of 10 to 20 milliliters or grams is typically sufficient to cover testing, retention, and repeat analysis. Exact quantities depend on the number of regulatory endpoints requested and the physical form of the substance.

How long does skin irritation testing take?

In vitro RhE tests are typically completed within one to two weeks once testing is initiated, including tissue conditioning, exposure, viability measurement, and reporting. Studies incorporating weight-of-evidence review, method selection, and quality review of the final report generally require two to four weeks overall. In vivo studies, when required, span a standard 14-day observation period plus pre-study preparation.

Can extreme pH values alone justify a corrosive classification?

Yes. Chemicals with a pH of 2 or lower, or 11.5 or higher, are presumed corrosive and are not tested further for corrosion when buffering capacity supports the classification. This screening logic, embedded in OECD TG 404 and ECHA guidance, avoids unnecessary testing on clearly hazardous substances.

How are test results used in GHS classification?

RhE viability results, TER resistance values, and in vivo Draize scores are mapped to defined classification criteria. For example, mean viability at or below 50 percent after a 42-minute RhE exposure supports corrosivity, while viability below 42 percent in the irritation protocol supports Category 2 classification. These determinations translate directly into hazard pictograms, signal words, and precautionary statements on labels and safety data sheets.

Should testing be conducted at an accredited laboratory?

Yes. Regulatory submissions should rely on data generated by accredited third-party laboratories operating in compliance with OECD Principles of Good Laboratory Practice (GLP). GLP-compliant reports ensure study integrity, traceability, and acceptance by regulatory authorities across jurisdictions.